Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Shanthi Rexaline

FOUND: What s next for novavax stock as covid vaccine clears key hurdle in us - You Need To See This

After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ:NVAX) can now heave a sigh of relief.

Adcom Unanimously Backs Novavax: FDA's Vaccines and Related Biological Products Advisory Committee that reviewed the Gaithersburg, Maryland-based company's biologic license application decided to unanimously recommend approval of the first protein-based vaccine candidate in the U.S. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.